Skip to main content
. 2019 Aug 22;17:105. doi: 10.1186/s12964-019-0422-7

Table 1.

Clinicopathologic characteristics of breast cancer patients with different ITM2A expression from the TCGA database

Characteristic No. (%) of patients Correlation
Total ITM2A high ITM2A low Chi-square p value
Age in years 1208 6.048 0.0139
  ≤ 60 285 362
  > 60 208 353
ER status 1145 3.016 0.0824
 Positive 382 504
 Negative 96 163
PR status 1142 6.734 0.0095
 Positive 340 427
 Negative 136 239
HER2 level 2.726 0.2559
 1+ 122 160
 2+ 75 134
 3+ 39 57
T classification 1205 12.67 0.0018
 T1 145 164
 T2 256 443
 T3/T4 92 105
N classification 1185 8.345 0.0394
 N0 261 300
 N1 220 191
 N2 68 64
 N3 49 32
Stage 1199 14.62 0.0022
 I 92 110
 II 254 432
 III 134 141
 Other 11 25

ER estrogen receptor, PR progesterone receptor, HER2 receptor tyrosine-protein kinase erbB-2